Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Inhibition of Late and Early Phases of Cancer Metastasis by the NF-κB Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review.

Lin Y, Ukaji T, Koide N, Umezawa K.

Int J Mol Sci. 2018 Mar 3;19(3). pii: E729. doi: 10.3390/ijms19030729. Review.

2.

Therapeutic activity of plant-derived alkaloid conophylline on metabolic syndrome and neurodegenerative disease models.

Umezawa K, Kojima I, Simizu S, Lin Y, Fukatsu H, Koide N, Nakade Y, Yoneda M.

Hum Cell. 2018 Apr;31(2):95-101. doi: 10.1007/s13577-017-0196-4. Epub 2017 Dec 16. Review.

PMID:
29249016
3.

Novel p-terphenyl glycoside with a rare 2,6-dideoxyhexopyranose moiety from Actinomycete strain SF2911 that inhibits cancer cell migration.

Wang L, Li M, Tang J, Lin Y, Sidthipong K, Sumida N, Kushida N, Umezawa K.

J Antibiot (Tokyo). 2017 Oct;70(10):987-990. doi: 10.1038/ja.2017.83. Epub 2017 Jul 19.

PMID:
28951608
4.

Inhibition of MMP-2-mediated cellular invasion by NF-κB inhibitor DHMEQ in 3D culture of breast carcinoma MDA-MB-231 cells: A model for early phase of metastasis.

Ukaji T, Lin Y, Okada S, Umezawa K.

Biochem Biophys Res Commun. 2017 Mar 25;485(1):76-81. doi: 10.1016/j.bbrc.2017.02.022. Epub 2017 Feb 8.

PMID:
28188787
5.

Inhibition of IGF-1-Mediated Cellular Migration and Invasion by Migracin A in Ovarian Clear Cell Carcinoma Cells.

Ukaji T, Lin Y, Banno K, Okada S, Umezawa K.

PLoS One. 2015 Sep 11;10(9):e0137663. doi: 10.1371/journal.pone.0137663. eCollection 2015.

Supplemental Content

Loading ...
Support Center